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Celiac disease is activated in genetically susceptible individuals by the ingestion 
of dietary gluten and similar proteins in other grains (reviewed in  1). The HLA 
class  II  specificity  DQw2  (previously  known  as  DC3  or  MB2)  is  present,  as 
assessed serologically, in 80-90%  of individuals with clinically diagnosed celiac 
disease (2-4).  However, ~25%  of the normal population also has this serologic 
marker and ingests dietary gluten without the development of disease (3). This 
observation suggests that the HLA antigen associated with increased susceptibility 
to celiac disease may be a  subspecificity of HLA-DQw2, or may be encoded by 
another HLA-D region locus that is in linkage disequilibrium with the DQ locus. 
To identify such a celiac disease-associated HLA-D region specificity, we exam- 
ined the structure of class  II  HLA genes in celiac disease  patients and control 
subjects using restriction fragment length polymorphism (RFLP) analysis (5). We 
now report a  polymorphic 4.0  kb Rsa  I  fragment detected using a  DQ/3 chain 
cDNA probe. This 4.0 kb fragment provides a  more accurate means of identi- 
fying individuals at risk for the development of celiac disease than the serologic 
marker, HLA-DQw2. 
Materials and Methods 
Patient and Control Cell Lines.  Patients for these studies were 20 unrelated Caucasians 
with  clinically diagnosed  celiac  disease.  Diagnosis  was  based  on  clinical  evidence of 
malabsorption, a small bowel biopsy compatible with celiac disease, clinical and/or biopsy 
improvement on a gluten-free diet, and clinical and/or biopsy abnormalities upon rechal- 
lenge with a gluten-containing diet. Controls were 11 unrelated individuals without clinical 
evidence of celiac disease.  Patients  and  controls in  this  study were  HLA  typed by a 
standard complement-dependent microcytotoxicity  assay, and were all positive for at least 
one allele of DQw2. Lymphoblastoid B cell lines were initiated from donors by culturing 
5  X  10  6  peripheral  blood  leukocytes with  supernatant  from  the  Epstein-Barr  virus- 
producing cell line,  1437, in the presence of 2 ttg/ml cyclosporin A. These B cell lines 
were maintained in  RPMI  1640 culture medium supplemented with  2 mM glutamine, 
100 U/ml penicillin, 100 #g/ml streptomycin and 10% FCS. 
DNA Purification.  Nuclei from B cell lines were prepared by lysis of l0  s cells in 20 ml 
of 10 mM Tris HCI (ph 8.0),  150 mM sodium chloride, 1 mM magnesium chloride, and 
0.5% NP-40. After centrifugation at 750 g, the nuclear pellet was resuspended in 75 mM 
sodium chloride, 25 mM EDTA with gentle pipetting. SDS and proteinase K were added 
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to final  concentrations  of 0.5%  and  200 ~g/ml,  respectively, and after  16  h  at  37°C, 
solutions were extracted twice with phenol/chloroform/isopentyl  alcohol (25:24:1),  and 
once with chloroform/isopentyl alcohol (24:1). After the addition of one-half the volume 
of 7.5  M ammonium acetate, nucleic acids were precipitated with ethanol and dissolved 
in  10 mM Tris HCI (pH 8.0) with 1 mM EDTA (TE buffer). 
RFLP Analysis.  15 ~g of high molecular weight DNA from patient and control samples 
were  digested  for  16  h  with  37.5  U  of restriction  endonuclease  in  accordance  with 
manufacturer's specifications. Reactions were terminated by the addition  of EDTA (10 
mM final concentration) and ammonium acetate (2.5  M final concentration), and DNA 
was precipitated with ethanol. After centrifugation, DNA pellets were dried under vacuum 
and resuspended in  TE.  Restriction endonuclease-digested genomic DNA was electro- 
phoresed in 0.8% agarose gels in Tris/acetate/EDTA (6).  Gels were acid-pretreated (7) 
and blotted overnight onto nitrocellulose as described by Southern (8). Blots were baked 
3 h  at 80°C  and hybridized essentially as described (7).  Briefly, nitrocellulose was wet 
with 2× SSC (Ix SSC is 150 mm sodium chloride, 15 mm sodium citrate), then prehybri- 
dized for 6 h at 42°C in 50% deionized formamide, 5× SSC, 5× Denhardt's additives, 50 
mM  sodium  phosphate,  and  250  ug/ml  denatured  salmon  testes  DNA.  Subsequently, 
hybridization was conducted overnight at 42°C in 50% deionized formamide, 5× SSC, 
5× Denhardt's additives, 20 mM sodium phosphate,  100 ~g/ml denatured salmon testes 
DNA,  10% dextran sulfate, and 2 ×  106 cpm/ml of probe nick-translated to 2-4 ×  l0 s 
cpm/lzg sp act. Blots were washed three times with 2× SSC, 0.1% SDS for 5 rain at room 
temperature, twice with 0.1× SSC,  0.1% SDS for 30 rain at 60°C and exposed to Kodak 
X-AR5 x-ray film with intensifying screens for 3 d. 
Hybridization Probes.  Probes  used  in  these  studies  were molecularly cloned  cDNAs 
encoding a DQ B chain (plI B-l)  °, a DR B chain (plI ~-3) 1°, and a DQ a chain (plI a-5) 1~, 
all provided by Dr. D. Larhammar, University of Uppsala, Uppsala, Sweden. 
Results 
Patient  and  control  DNA  samples were  digested  with  a  panel  of restriction 
endonucleases  including  Barn  HI,  Eco  RI,  Hind  III, and  Pst  I,  enzymes  with 
hexanucleotide recognition sequences, and Rsa I, which cleaves at a tetranucleo- 
tide site.  Digests  were  screened by Southern  blot analysis using  DQ and  DR 
chain cDNA probes. 
The  restriction  endonuclease  Rsa  I  revealed  a  disease-associated  RFLP  that 
was detectable by hybridization  to the DQ ~ chain cDNA probe (Fig.  1).  Of the 
10 celiac disease patient  DNA's shown  in  Fig.  1 (lanes  1-10),  9  possessed a  4.0 
kb fragment  that  was present  in  only one  of the  five control  DNA  samples in 
Fig.  1 (lanes 11-15).  This fragment was not observed in hybridizations that used 
DR  /~ (pli8-3)  or  DQ  a  (plIa-5)  chain  cDNA  probes,  indicating  that  it  is  not 
derived  from  these genes,  but  arises from the  DQ B chain  gene  or one  with  a 
high degree of sequence homology. Table I lists, individually,  the entire patient 
and control populations that we have screened to date. We have found 90% (18 
of 20)  of DQw2  celiac patients  and  18%  (2  of 11)  of DQw2  controls  that  are 
positive for the 4.0  kb Rsa I  fragment. Consequently,  in  DQw2 individuals,  the 
relative risk (12)  of developing celiac disease  is 40-fold greater in  the  presence 
of this fragment than in its absence (X  2 =  15.98, p  << 0.001). 
Discussion 
This study describes a  means for distinguishing  the HLA-D region haplotype 
associated with celiac disease from a  serologically identical  haplotype present in 
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FIGURE  1.  Rsa  I-digested  genomic DNA  from celiac disease patients (lanes 1-10) and 
controls (lanes 11-15) hybridized to a 780-bp Pst l-Eco RI fragment ofpll/3-I (DQ # probe). 
HLA-DR and -DQ types are indicated below each sample. Arrow shows position of 4.0-kb 
RFLP. Bars in the right hand margin denote mobilities  of Hind III fragments of bacteriophage 
k DNA (in descending order 6.6, 4.3, 2.2, 2.1, and 0.56 kb). 
associated  with  celiac  disease are  HLA-DR3,  -DQw2  and  HEA-DR7,  -DQw2. 
Each of the individuals in our patient and control populations was seropositive 
for one of these haplotypes, yet the 4.0  kb Rsa I  fragment was predominantly 
associated  with  the  HLA-D  region  genes of celiac disease patients.  Given  this 
strong association with disease, it is possible that the fragment is derived directly 
from a  celiac disease susceptibility gene.  Alternatively, it may be derived from 
an HLA-D region/3 chain gene that does not confer disease susceptibility but is 
in tight linkage disequilibrium with one that does.  Regardless, the detection of 
this fragment provides a  molecular genetic marker that can be used to identify 
the celiac disease haplotype, and may ultimately be  used to locate the  HLA-D 
region gene(s) predisposing for celiac disease. 
All D region/3 chain genes share varying degrees of sequence homology, which 
permits  crosshybridization  in  Southern  blot  analysis  (5,  13-15).  Therefore, 
detection of the  4.0  kb  RFLP with a  DQ/3  chain probe  does not conclusively 
map this fragment to the DQ  locus. Given the lack of hybridization to the DR 
probe, the 4.0 kb RFLP is probably not a  DR #  chain gene fragment. However, 
we cannot preclude the possibility that the 4.0  kb fragment is part of a/3 chain 
gene derived from a  D  region locus other than DQ or DR. The identity of the 
HLA-D  region  locus  from  which  the  fragment  is  derived  is  currently  under 
study. 
Finally, a  gene fragment similar or identical to the 4.0 kb RFLP identified in 
our studies is also found in individuals with insulin-dependent diabetes mellitus 
(IDDM).  Arnheim,  et  al.  (16)  have  used  RFLP  analyses to  study the  HLA-D 336  HOWELL  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TAnLE  I 
Patient and Control Populations 
Presence of 4.0-kb 
Patient  DR  DQw  RFLP 
1  2,3  1,2 
2  1,3  1,2 
3  3,7  2,3 
4  3,7  2,-- 
5  3,7  2,-- 
6  3,4  2,3 
7  3,--  2,-- 
8  3,--  2,-- 
9  3,7  2,2 
10  3, 3  2, 2 
11  2,7  1,2 
12  3,6  1,2 
13  5,7  2,3 
14  3,5  2,3 
15  3,6  1,2 
16  3,-  2, 3 
17  3, --  2, -- 
18  3, 7  2, -- 
19  3,2  1,2 
2O  3,4  2,3 
+ 
.4- 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Total:  18+, 2- 
Control subject 
1  3,3  2,2  - 
2  3,3  2,2  - 
3  3,3  2,2  + 
4  3,3  2,2  - 
5  3,3  2,2  + 
6  7,7  2,2  - 
7  7,7  2,2  - 
8  7,7  2,2  - 
9  7,7  2,2  - 
10  1,7  1,2  - 
11  7,9  2,--  - 
Total:  2+, 9- 
region genes of IDDM patients.  It is apparent from data in that report, although 
not specifically  stated by the authors, that the 4.0  kb Rsa I fragment is present 
in  the  DNA  of IDDM  patients  but not in  that  of controls.  This  is interesting, 
because an association between celiac disease and IDDM is well recognized (17). 
Serologically,  a common denominator between  celiac  disease and IDDM  is the 
increased frequency in both of HLA-DR3 (2). That the HLA-D region haplotypes 
associated  with  both  diseases  are  similar  at  the  DNA  level  suggests  that  the 
immunological mechanisms that mediate these disparate diseases share, to some 
degree, a common etiology. 
Summary 
This  study is the  first to describe  a  molecular  marker  that  distinguishes  the 
celiac  disease HLA-D region  haplotype from a serologically  identical  haplotype 
in  unaffected  controls.  Using  a  DQ/3  chain  cDNA  probe  and  the  restriction 
endonuclease Rsa I, we have detected a polymorphic 4.0 kb fragment which,  in 
DQw2  individuals,  is associated  with a  40-fold  increased  relative  risk of devel- 
oping celiac  disease.  This finding should permit the identification  of the celiac 
disease susceptibility gene(s)  in the HLA-D  region and facilitate a more precise HOWELL  ET  AL.  BRIEF  DEFINITIVE REPORT  337 
dissection  of  the  molecular  and  immunogenetic  mechanisms  involved  in  the 
pathogenesis of that disease. 
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